fludarabine has been researched along with loxoribine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magagnoli, M; Ottaviani, E; Pellacani, A; Tosi, P; Tura, S; Zinzani, PL | 1 |
| Albertini, P; Magagnoli, M; Ottaviani, E; Pellacani, A; Tosi, P; Tura, S; Zinzani, PL | 1 |
2 other study(ies) available for fludarabine and loxoribine
| Article | Year |
|---|---|
Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Drug Interactions; Drug Screening Assays, Antitumor; Female; Guanosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Cells, Cultured; Vidarabine | 1997 |
Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Guanosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Cells, Cultured; Vidarabine | 1999 |